Rapid Micro Biosystems Q2 revenue up 10%, beats estimates
Overview
Rapid Micro Biosystems Q2 revenue grows 10%, beating analyst expectations
Net loss for Q2 was $11.9 mln, missing analyst estimates
Co enters $45 mln loan facility to strengthen financial position
Outlook
Company reaffirms full-year 2025 revenue guidance of at least $32 mln
Company expects new loan facility to support long-term growth
Rapid Micro Biosystems aims for positive cash flow in 2025
Company focuses on revenue growth and gross margin expansion
Result Drivers
SERVICE REVENUE - Service revenue grew by 18%, contributing significantly to overall revenue growth
PRODUCT REVENUE - Product revenue increased by 6%, led by mid-teens growth in consumables
GROSS MARGIN IMPROVEMENT - Gross margin improved by seven percentage points, indicating better cost management
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $7.30 mln | $7.03 mln (3 Analysts) |
Q2 EPS |
| -$0.27 |
|
Q2 Net Income | Miss | -$11.90 mln | -$11.10 mln (3 Analysts) |
Q2 Operating Expenses |
| $12.40 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00, about 59.3% above its August 11 closing price of $3.26
Press Release: ID:nGNX80v8c6
Related Articles
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing..jpg)
Investing in Quantum Computing
TradingKey - What was once confined to university labs and science fiction books is now becoming one of the most disruptive technologies of the next twenty years, set to transform industries from pharmaceuticals and materials science to finance, logistics, and climate modeling.
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
